Dr. Gregory John Martin, Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Medicare Enrolled Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7000 |
Dr. Kathleen Ann O'connor, MD Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Evergreen Pkwy Nw, Sem I, 2110, Olympia, WA 98505 Phone: 360-867-6200 |
Dr. Ryan Douglass Herrington, MD MPH Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 203 4th Ave E Ste 501, Olympia, WA 98501 Phone: 614-256-5071 |
Dr. Miriam Louise Fields, MD, MPH Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 6035 Woodard Bay Rd Ne, Olympia, WA 98506 Phone: 360-754-1307 |
Mariel L Plaeger-brockway, Preventive Medicine - Occupational Medicine Medicare: Medicare Enrolled Practice Location: 525 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-493-4002 Fax: 360-493-5524 |
Kyrah Holland, Preventive Medicine - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Yauger Way Sw Unit G108, Olympia, WA 98502 Phone: 313-695-1761 |
Dr. Alan M. Steinman, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 4720 Cooper Point Rd Nw, Olympia, WA 98502 Phone: 253-229-4088 |
Dr. John Paul Holland, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 9226 Milburn Loop Se, Olympia, WA 98513 Phone: 206-200-5020 Fax: 360-786-6016 |
News Archive
Today, the way a physician gets an idea of how many seizures a person with epilepsy has had is through the patient's own record of seizure activity in his day-to-day life.
The Institute of Cancer Research, London, Cancer Research Technology, London and Nuevolution A/S, Copenhagen have entered into a drug discovery collaboration to identify novel lead candidates for cancer treatment.
A medical researcher at The University of Auckland says antibiotics are still being overused for treating common colds in New Zealand, despite researching showing their ineffectiveness.
Cerenis Therapeutics SA, a privately held biopharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, today announced it will present the results of two clinical proof-of-concept studies for its CER-627 program (niacin/aspirin combinations) at the 78th European Atherosclerosis Society Congress on June 20-23 in Hamburg, Germany.
› Verified 3 days ago